All NEW, for you, Compound Management & Integrity 2008…
New for CM 2008
CM 2008 will be co-located with the inaugural conference, Lead-Finding Screening 2008.
Without changing the tight focus on Compound Management & Integrity, joint roundtable discussions, workshops and networking opportunities will be used to facilitate discussion of best practices of how to improve the critical interface between CM and Screening.
Great as usual - best place to have face-to-face conversations with leaders in the CM community.
Ioana Popa-Burke, Head of SHARP, GlaxoSmithKline
Most valuable conference for CM. Excellent presentations, good networking as a source of new ideas for implementation.
Eva Maria Gutknecht, Head of Compound Logistics, F. Hoffman La Roche
I will be back next year. Excellent balance of large and small pharmas, world experts and appropriate vendors - a great networking opportunity.
Terry Wood, Head of Liquid Store Centre of Emphasis, Pfizer Global R&D
With the mounting pressure on drug discovery organisations to perform, it’s your responsibility to contribute to decreasing bottlenecks and gain process efficiencies, wherever you can. Compound Managers today are also expected to generate as much QA data early on to ensure downstream success. In fact, your colleagues in screening and research rely on it.
CM 2008 will show you how industry leaders are rising to these challenges and not only efficiently storing and supplying compounds, but also advancing the science of compound handling and concentration determination to have a significant positive impact on lead discovery projects.
Don’t miss the Focus Day on ‘How to Improve the Critical Interface between CM, Screening & Research teams’ to learn how companies across the industry are taking advantage of growth opportunities afforded by improving these interfaces, and developing more direct processes and defined workflows.
Learn how you can make key contributions to lead discovery success at CM 2008
The definitive meeting place for top professionals working in Compound Management
The Pharma IQ annual Compound Management & Integrity event has become the meeting place for industry thought leaders, senior directors and scientists in Compound Management, HTS, Lead Discovery, Medicinal and Analytical Chemistry to discuss the latest practices and technology being applied for compound logistics, automation from store to screen, analytical quantitation, and how to best utilise the valuable quality data in lead discovery.
30+ NEW forward-thinking sessions, including speakers:
 |
Dr. Ricardo Macarron
Vice President of Compound Management
GlaxoSmithKline & President of the SBS
|
 |
Kimberly A. Matus
Associate Director, Discovery Chemistry Sourcing
Pfizer Global R&D
|
 |
Christine Rigby
Associate Director Compound Management Group, Global Compound Sciences
AstraZeneca
|
 |
Janet Cheetham
Executive Director
Amgen
|
 |
Dr. Timo Flessner
Director, Head of Medicinal Chemistry 5
Bayer Schering Pharma
|
 |
Dr. David Camp
Director, Eskitis Institute for Cell & Molecular Therapies
Griffith University
|
 |
Dr. Terry Wood
Head of Liquid Store Centre of Emphasis
Pfizer Global R&D
|
 |
Gwendolyn Goedbloed
Associate Director, Virology Laboratory Operations
Tibotec BVBA
|
 |
Joe Bradley
HTS Centre of Emphasis
Pfizer
|
 |
Dr. Snehal Bhatt
Manager, Automatic Liquid Store
GlaxoSmithKline
|
Don't miss your opportunity...
The 5th annual Compound Management & Integrity conference will provide you with the most current issues facing Compound Managers, Screening and Analytics professionals. Presentations from big and medium size pharmas will give you the knowledge how to update your compound logistics, automation, QC and library for lead-finding success.
If you are not yet ready to register, feel free to request a reminder nearer the time.
Conference Partners
| Session Sponsors |
Delegate Package Sponsor |
Roundtable Sponsor |
 |
|
 |
| Workshop Sponsor |
Featured Exhibitors |
Media Partners |
 |
 |
 |
[ Register Now]
· [ Next: Focus Day: 20th May 2008 ]